Company Analysis

XBiotech Inc. (XBIT)

Nasdaq: XBIT · Pharmaceutical Preparations · Austin, TX · filing with the SEC since 2014
Grade5.3
◀ Past 4.8● Present 5.0▶ Future 6.0
4 est.

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedMar 13, 2026Mar 18, 2025Mar 15, 2024Mar 15, 2023Mar 15, 2022Mar 16, 2021Mar 16, 2020Mar 14, 2019Mar 16, 2018Mar 16, 2017
Revenue··0.04,010.018,394.043,997.00.00.0··
Cost of revenue··0.0651.05,820.034,548.00.00.0··
Gross profit··0.03,359.012,574.09,449.00.00.0··
Research and development47,390.037,757.032,848.031,544.028,268.09,527.024,090.015,725.026,424.042,486.0
General and administrative8,295.04,714.04,662.06,305.09,388.018,198.07,143.05,269.07,635.010,277.0
Total operating expenses·42,471.037,510.037,849.037,656.027,725.031,233.020,994.034,059.052,763.0
Operating income-55,685.0-42,471.0-37,510.0-34,490.0-25,082.0-18,276.0-31,233.0-20,994.0-34,059.0-52,763.0
Interest and investment income5,679.09,812.010,421.03,823.0467.02,456.0564.0400.0354.049.0
Interest income (expense), net-88.0-807.00.0·······
Other income (expense), net1,456.0432.0883.0-121.0-132.0-503.010.04.0··
Total non-operating income (expense)10,380.03,908.013,197.0902.0-376.05,449.0749,686.0-144.0909.02.0
Income before income taxes-45,305.0-38,563.0-24,313.0-33,588.0-25,458.0-12,827.0718,453.0-21,138.0-33,150.0-52,761.0
Income tax expense235.0-32.0244.0-688.0-8,044.0-1,606.049,824.00.00.00.0
Net income-45,540.0-38,531.0-24,557.0-32,900.0-17,414.0-11,221.0668,629.0-21,138.0-33,150.0-52,761.0r
Earnings per share, basic-1.49-1.26-0.81-1.08-0.58-0.3617.17-0.59-0.95·
Earnings per share, diluted-1.49-1.26-0.81-1.08-0.58-0.3614.44-0.59-0.95·
Earnings per share, basic and diluted·······-0.59-0.95-1.63
Weighted average shares, basic30,487,73130,460,98030,438,45930,439,27530,043,38030,823,45838,945,46835,804,30434,875,814·
Weighted average shares, diluted30,487,73130,460,98030,438,45930,439,27530,043,38030,823,45846,319,45735,804,30434,875,814·
Weighted average shares, basic and diluted·······35,804,30434,875,81432,403,391
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold
Gross profit revenue less the cost of what it soldus-gaap:GrossProfit
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeNet
Interest income (expense), net interest earned less interest paid, outside the businessus-gaap:InterestIncomeExpenseNonoperatingNet
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton XBIT · research, not advice